Table 7 Multivariate analysis of echocardiographic findings among the study (diabetic) group
Diastolic dysfunction (n = 82) | OR (95% CI) | P value |
|---|---|---|
Combined use of Metformin and Sulfonylureas | 0.147 (0.028 – 0.763) | 0.02 |
High triglyceride level | 0.385 (0.154 – 0.961) | 0.04 |
Dyslipidemia | 0.356 (0.132 – 0.960) | 0.04 |
Dyslipidemia | 0.264 (0.098 – 0.713) | 0.009 |
Atorvastatin use | 0.375 (0.114 – 1.26) | 0.033 |
Neuropathy | 0.048 (0.004 - 0.552) | 0.015 |
Reduced left ventricular ejection fraction (< 50%) | ||
Chronic kidney disease | 0.193 (0.04 - 0.920) | 0.039 |
Neuropathy | 0.257 (0.071 – 0.929) | 0.038 |